Cargando…

Effect of combination therapy with pramipexole and n-acetylcysteine on global cerebral ischemic reperfusion injury in rats

OBJECTIVE(S): The study was intended to investigate the combined influence of two neuroprotective agents pramipexole and n-acetylcysteine on global cerebral ischemic reperfusion injury (GCIRI) model in rats. MATERIALS AND METHODS: GCIRI was induced by bilateral common carotid artery ligation (BCCA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danduga, Ravi Chandra Sekhara Reddy, Reddy, Dondapati Subba, Seshadri, Singapalli Meenakshi, Has, Kavati Sanith Satya, Kumar, Kola Phani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015253/ https://www.ncbi.nlm.nih.gov/pubmed/29942446 http://dx.doi.org/10.22038/IJBMS.2018.22647.5756

Ejemplares similares

COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review
por: Raj, C. T. Dhanya, et al.
Publicado: (2021)

Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke
por: Andrabi, Syed Suhail, et al.
Publicado: (2019)

The Effects of Remote Ischemic Preconditioning and N-Acetylcysteine with Remote Ischemic Preconditioning in Rat Hepatic Ischemia Reperfusion Injury Model
por: Uysal, Ali Ihsan, et al.
Publicado: (2014)

Pramipexole use and the risk of pneumonia
por: Ernst, Pierre, et al.
Publicado: (2012)

Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006)

Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
por: ELSHIEKH, Mohammed, et al.
Publicado: (2019)

Burning mouth syndrome responsive to pramipexol
por: Stuginski-Barbosa, J., et al.
Publicado: (2008)

Automatic behavior and communication due to pramipexole
por: Walker, Ruth H.
Publicado: (2016)

An Evaluation of the Effectiveness of Melatonin and n-Acetylcysteine in Cerebral Ischemia-Reperfusion Injury in Adult Rats
por: Aydin, Hilal, et al.
Publicado: (2023)

Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Constantinescu, Radu
Publicado: (2008)

Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole
por: Ferrari-Toninelli, Giulia, et al.
Publicado: (2010)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

Gold nanoclusters as prospective carriers and detectors of pramipexole
por: Si, Nguyen Thanh, et al.
Publicado: (2021)

Pramipexole in the Treatment of Refractory Depression in a Patient with Rapid Cycling Bipolar Disorder
por: Hegde, Aditya, et al.
Publicado: (2015)

Restless legs syndrome: differential diagnosis and management with pramipexole
por: Brindani, Francesca, et al.
Publicado: (2009)

Pramipexole effects on startle gating in rats and normal men
por: Swerdlow, Neal R., et al.
Publicado: (2009)

Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
por: Chau, Kai-Yin, et al.
Publicado: (2013)

Pramipexole and its Extended Release Formulation for Parkinson’s Disease
por: Fishman, Paul S.
Publicado: (2011)

Analysis of pramipexole dose–response relationships in Parkinson’s disease
por: Wang, Ying, et al.
Publicado: (2016)

Effect of Venlafaxine, Pramipexole, and Valsartan on Spermatogenesis in Male Rats
por: Saleem, Uzma, et al.
Publicado: (2020)

SAT-203 Misleading Diagnosis of Cushing’s Syndrome on Pramipexole
por: Pahomov, Elizabeth, et al.
Publicado: (2020)

High-degree atrioventricular heart block induced by pramipexole
por: Kanal, Yücel, et al.
Publicado: (2022)

Pramipexole Inhibits Neuronal Apoptosis in Rats with Parkinson's Disease
por: Sun, Yongqi, et al.
Publicado: (2022)

S-Nitroso-N-Acetylcysteine Ameliorates Ischemia-Reperfusion Injury In The Steatotic Liver
por: Andraus, Wellington, et al.
Publicado: (2010)

N-Acetylcysteine Reduced Ischemia and Reperfusion Damage Associated with Steatohepatitis in Mice
por: Chaves Cayuela, Natalie, et al.
Publicado: (2020)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
por: Deutschländer, Angela, et al.
Publicado: (2016)

Beneficial effect of pramipexole for motor function and depression in Parkinson’s disease
por: Kano, Osamu, et al.
Publicado: (2008)

Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride
por: Hoang, Mylien T., et al.
Publicado: (2015)

Comorbid Functional Shoulder Pain and Zolpidem Dependence Treated with Pramipexole
por: Kandre, Dhiraj, et al.
Publicado: (2015)

A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole
por: Putri, Ratih S. I., et al.
Publicado: (2016)

Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
por: Gallant, Haley, et al.
Publicado: (2016)

Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
por: Yang, Xue Qing, et al.
Publicado: (2016)

Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
por: Ventorp, Filip, et al.
Publicado: (2022)

Pramipexole modulates fronto-subthalamic pathway in sequential working memory
por: Heldmann, Marcus, et al.
Publicado: (2022)

Retracted: Pramipexole Inhibits Neuronal Apoptosis in Rats with Parkinson's Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Renoprotective effect of N-acetylcysteine depends upon the severity of the ischemia reperfusion injury
por: Watanabe, M., et al.
Publicado: (2021)

Effects of N-Acetylcysteine and N-Acetylcysteine Amide on Erythrocyte Deformability and Oxidative Stress in a Rat Model of Lower Extremity Ischemia-Reperfusion Injury
por: Erol, Gokhan, et al.
Publicado: (2020)

N-acetylcysteine Prevents Kidney and Lung Disturbances in Renal Ischemia/Reperfusion Injury in Rat
por: Azarkish, Fariba, et al.
Publicado: (2013)

Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease
por: Eisenreich, Wolfram, et al.
Publicado: (2010)

Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_edpop8tjv7gof9l6otbp8igpnl